← Open Payments lookup

SAI-SUN HO: Open Payments

NPI 1710952957 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,641 in 67 payments from 15 companies in 2025. Trend: 2023 $4,149 · 2024 $3,797 · 2025 $2,641

Food & beverage: $2,641
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$556
Boehringer Ingelheim Pharmaceuticals, Inc.11$488
Novo Nordisk Inc9$334
GlaxoSmithKline, LLC.10$313
Bayer Healthcare Pharmaceuticals Inc.8$234
Lilly USA, LLC3$183
Kowa Pharmaceuticals America, Inc.2$147
PFIZER INC.1$119
Gilead Sciences, Inc.3$92
Sumitomo Pharma America, Inc.2$44

Products named: TRELEGY ELLIPTA, JARDIANCE, BREZTRI, Kerendia, FARXIGA, Ozempic, OFEV, ZORYVE.

Industry payments across CA — which companies pay providers there.